Aardvark Therapeutics, Inc. (AARD)
1.35
+0.18
(+15.38%)
USD |
NASDAQ |
Nov 09, 11:48
Aardvark Therapeutics Price to Book Value : 0.3950 for Nov. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 06, 2026 | 0.3423 |
| November 05, 2026 | 0.3248 |
| November 04, 2026 | 0.3687 |
| November 03, 2026 | 0.3599 |
| November 02, 2026 | 0.3511 |
| October 30, 2026 | 0.3979 |
| October 29, 2026 | 0.4213 |
| October 28, 2026 | 0.4418 |
| October 27, 2026 | 0.3804 |
| October 26, 2026 | 0.316 |
| October 23, 2026 | 0.4067 |
| October 22, 2026 | 1.156 |
| October 21, 2026 | 1.290 |
| October 20, 2026 | 1.141 |
| October 19, 2026 | 1.094 |
| October 16, 2026 | 1.106 |
| October 15, 2026 | 1.129 |
| October 14, 2026 | 1.135 |
| October 13, 2026 | 1.182 |
| October 12, 2026 | 1.302 |
| October 09, 2026 | 1.393 |
| October 08, 2026 | 1.378 |
| October 07, 2026 | 1.451 |
| October 06, 2026 | 1.475 |
| October 05, 2026 | 1.527 |
| Date | Value |
|---|---|
| October 02, 2026 | 1.46 |
| October 01, 2026 | 1.542 |
| September 30, 2026 | 1.542 |
| September 29, 2026 | 1.565 |
| September 28, 2026 | 1.542 |
| September 25, 2026 | 1.480 |
| September 24, 2026 | 1.624 |
| September 23, 2026 | 1.627 |
| September 22, 2026 | 1.682 |
| September 21, 2026 | 1.630 |
| September 18, 2026 | 1.574 |
| September 17, 2026 | 1.618 |
| September 16, 2026 | 1.507 |
| September 15, 2026 | 1.469 |
| September 14, 2026 | 1.624 |
| September 11, 2026 | 1.501 |
| September 10, 2026 | 1.466 |
| September 09, 2026 | 1.440 |
| September 08, 2026 | 1.560 |
| September 04, 2026 | 1.574 |
| September 03, 2026 | 1.676 |
| September 02, 2026 | 1.741 |
| September 01, 2026 | 1.732 |
| August 31, 2026 | 1.785 |
| August 28, 2026 | 1.694 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Johnson & Johnson | 8.249 |
| Bristol Myers Squibb Co. | 5.437 |
| ANI Pharmaceuticals, Inc. | 2.430 |
| Corcept Therapeutics, Inc. | 9.950 |
| Veru, Inc. | 1.316 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0047 |
| Price | 1.35 |
| Earnings Yield | -237.4% |
| Market Cap | 29.54M |
| PEGY Ratio | -0.0047 |